Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found that certain miRNAs, which affect immune system regulation, are differently expressed in mice with a hair loss condition compared to healthy mice.

Regulatory T cells and mesenchymal stem cells work together to prevent immune system overreactions and tissue damage.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

Hair follicle cells help protect against immune attacks by regulating T-cell activity.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

Janus kinase inhibitors show promise in treating autoimmune skin diseases.

Blocking IL-17 signaling may reduce skin inflammation and delay aging.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

Enhancing immune response can improve cancer treatment effectiveness.

IL-9/IL-9R signaling can negatively affect human hair growth and may be a target for treating hair loss conditions.

Targeting SOX proteins may improve cancer treatment by restoring immune function.

Regulatory T cells help prevent autoimmunity and have potential for treating autoimmune diseases.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

Targeting specific biomarkers and immune signals is more effective and safer for treating inflammatory skin diseases.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

IL-15 promotes hair growth and protects hair follicles.

Combining MMP-9 and JAK inhibitors can effectively prevent skin depigmentation in vitiligo.

Immune-epithelial interactions are crucial for tissue repair, but unchecked can cause diseases.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

Regulatory T cells protect hair follicle stem cells by maintaining immune privilege in the skin.

Blocking interferon-gamma might help treat various autoimmune diseases.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

B cells can both help and hinder the body's defense against melanoma.

ILC1-like cells can cause alopecia areata by affecting hair follicles.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.